SIRP alphaV2

SIRP alphaV2 詳細

英語名Signal-regulatory protein alpha市販薬剤の数2
治験薬の数19ターゲットの別称SHPS-1,Macrophage fusion receptor,Brain Ig-like molecule with tyrosine-based activation motifs,MFR,Signal-regulatory protein alpha-1,Signal-regulatory protein alpha-2,CD172a,MyD-1 antigen,Sirp-alpha-3,MYD1,SIRPA,Signal Regulatory Protein Alpha,CD172 Antigen-Like Family Member A,Inhibitory Receptor SHPS-1,PTPNS1,SHPS1,SIRP,P84,Brain-Immunoglobulin-Like Molecule With Tyrosine-Based Activation Motifs,Protein Tyrosine Phosphatase, Non-Receptor Type Substrate 1,Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1,Tyrosine Phosphatase SHP Substrate 1,Signal-Regulatory Protein Alpha-3,Signal-Regulatory Protein Alpha,SHP Substrate 1,CD172a Antigen,Sirp-Alpha-1,Sirp-Alpha-2,MYD-1,Bit,SIRPalpha,SIRPalpha2
研究&開発段階Approved
英語名Signal-regulatory protein alpha
ターゲットの別称SHPS-1,Macrophage fusion receptor,Brain Ig-like molecule with tyrosine-based activation motifs,MFR,Signal-regulatory protein alpha-1,Signal-regulatory protein alpha-2,CD172a,MyD-1 antigen,Sirp-alpha-3,MYD1,SIRPA,Signal Regulatory Protein Alpha,CD172 Antigen-Like Family Member A,Inhibitory Receptor SHPS-1,PTPNS1,SHPS1,SIRP,P84,Brain-Immunoglobulin-Like Molecule With Tyrosine-Based Activation Motifs,Protein Tyrosine Phosphatase, Non-Receptor Type Substrate 1,Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1,Tyrosine Phosphatase SHP Substrate 1,Signal-Regulatory Protein Alpha-3,Signal-Regulatory Protein Alpha,SHP Substrate 1,CD172a Antigen,Sirp-Alpha-1,Sirp-Alpha-2,MYD-1,Bit,SIRPalpha,SIRPalpha2
市販薬剤の数2
治験薬の数19
研究&開発段階Approved

SIRP alphaV2 製品リスト

  • 属性

    Protein (3)

  • 製品ライブラリ

    オンライン (3)

  • Human (3)

  • タグ

    His Tag & Avi Tag (1)His Tag (1)Llama IgG Fc Tag (1)

  • マーカー

    Biotin-labeled (1)Unconjugated (2)

SIRP alphaV2バックグランド

Tyrosine-protein phosphatase non-receptor type substrate 1 (SHPS1) is also known as CD172 antigen-like family member A (CD172a), Macrophage fusion receptor, MyD-1 antigen, Signal-regulatory protein alpha (SIRPA or SIRP alpha) or p84, is a member of the SIRP family, and also belongs to the immunoglobulin superfamily. SIRP alpha is Ubiquitous and highly expressed in brain. SIRPA / CD172a is immunoglobulin-like cell surface receptor for CD47 and acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. SIRPA / SHPS-1 supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment and may play a key role in intracellular signaling during synaptogenesis and in synaptic function By similarity. SIRPA / MyD1 involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin and mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells.

SIRP alphaV2分子の別称

SHPS1,SIRPA,CD172A,BIT,MFR,MYD1,P84,PTPNS1

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
IpsoprubartELA-026Phase 3 ClinicalElectra Therapeutics IncLymphohistiocytosis, Hemophagocytic; Neoplasms
詳細
LM-101LM-101Phase 2 ClinicalLaNova Medicines LtdHematologic Neoplasms; Leukemia; Neoplasms; Solid tumours
詳細
HX-044HX044; HX-044Phase 2 ClinicalHanx Biopharmaceuticals Pty LtdLymphoma; Solid tumours
詳細
BRB-002BRB-002Phase 2 ClinicalBitterroot Bio IncAtherosclerosis; Cardiovascular Diseases; Vasculitis
詳細
BI-770371BI-770371Phase 2 ClinicalOse ImmunotherapeuticsCarcinoma, Non-Small-Cell Lung; Liver Cirrhosis; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
IBC-0966IBC-0966Phase 2 ClinicalNeoplasms
詳細
HX-009HX-009; HX009-II-02Phase 2 ClinicalWaterstone Hanxbio Pty LtdBile Duct Neoplasms; Biliary Tract Neoplasms; Liver Neoplasms; Lymphoma; Melanoma; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
詳細
BI-765063OSE-172; BI-765063; Effi-DEMPhase 1 ClinicalEffimuneCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
ADU-1805ADU-1805Phase 1 ClinicalAduro Biotech IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Solid tumours
詳細
Q-1801Q-1801; Q 1801Phase 1 ClinicalQure Biotechnology (Shanghai) Co LtdSolid tumours
詳細
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo)DS-1103aPhase 1 ClinicalDaiichi Sankyo Co LtdBreast Neoplasms; Solid tumours
詳細
JY-47JY47; JY-47Phase 1 ClinicalHangzhou Jiuyuan Gene Biomedical Co LtdLiver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours
詳細
BYON-4228BYON-4228Phase 1 ClinicalSanquin Blood Supply FoundationLymphoma; Solid tumours
詳細
BSI-082BSI-082Phase 1 ClinicalBiosion IncHematologic Neoplasms; Neoplasm Metastasis; Solid tumours
詳細
BR-105BR-105; BR105Phase 1 ClinicalHisun Biopharmaceutical Co Ltd, Zhejiang BioRay Biopharmaceuticals Co LtdLymphoma, Large B-Cell, Diffuse; Neoplasms
詳細
[89Zr]Zr- BI-765063(Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim CorpCarcinoma, Non-Small-Cell Lung; Melanoma; Squamous Cell Carcinoma of Head and Neck
詳細
TQB-2928TQB-2928Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Osteosarcoma; Solid tumours
詳細
BI-765080Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
詳細
ES-004ES-004; ES 004-N4; ES 004-B4Phase 1 ClinicalElpiscience (Shanghai) Biopharma LtdNeoplasms; Solid tumours
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Relugolix/Estradiol/Norethindrone AcetateE2/NETAApprovedMyovant SciencesMYFEMBREE, RYEQOUnited StatesMenorrhagia; LeiomyomaSumitomo Pharma America Inc, Myovant Sciences2021-05-26Endometriosis; Leiomyoma; Menorrhagia; Pain; Uterine Neoplasms
詳細
Elagolix/estradiol/norethindrone acetateApprovedAbbvie IncOriahnnUnited StatesMenorrhagiaAbbvie Inc2020-05-29Menorrhagia
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8